The Log
Archive
266 stories, newest first.
May 2026
- May 8Science & Medicine
Alcohol: The Most Widely Used Drug in America, Explained
Alcohol pharmacology, biology, policy, and treatment in 2026 — including the three FDA-approved medications for alcohol use disorder and why they're underused.
- May 8Science & Medicine
Stimulants in 2026: Meth, Cocaine, and the Prescription Shadow
Stimulants in 2026 — meth, cocaine, and prescription stimulants: pharmacology, health effects, policy, trends, and what actually treats stimulant use disorder.
- May 8Science & Medicine
Opioids: The Definitive 2026 Guide
The 2026 definitive guide to opioids — pharmacology, brain effects, addiction mechanisms, policy, trends, treatment, and harm reduction.
- May 8Technology & Innovation
Pelago, Boulder, Workit, Ophelia — Who's Who in Digital Recovery
A reader-friendly map of the major digital recovery companies in 2026 — Pelago, Boulder Care, Workit, Ophelia, and others — and how they differ.
- May 8Treatment & Recovery
How 211 Fills the Gaps SAMHSA's Directory Can't
Why 211 is an essential companion to SAMHSA's directory — the nonclinical recovery services that make treatment stick.
- May 8Science & Medicine
What the Evidence Says About Psychedelic-Assisted Therapy for Addiction in 2026
An evidence review of psychedelic-assisted therapy for substance use disorder in 2026 — psilocybin, MDMA, ibogaine, ketamine, and the open questions.
- May 8Harm Reduction
Xylazine: What It Is, and Why It's Changing Overdose Response
Xylazine ("tranq") is a veterinary sedative now widely cut into the fentanyl supply. What it is, why naloxone only partly works, and how to respond.
- May 8Policy & Funding
DEA Extends Telemedicine Buprenorphine Rules Through 2026
DEA and HHS extended telemedicine prescribing flexibilities through 2026, and made telehealth buprenorphine permanent for 6 months of care.
- May 8Arizona Watch
The Arizona Opioid Settlement, Explained
Arizona's $1.215B opioid settlement, explained — state vs. county shares, how funds are spent, and what Maricopa County has funded so far.
- May 8Treatment & Recovery
MAT in 2026: What Medication-Assisted Treatment Is (and What It Isn't)
MAT in 2026, explained: how buprenorphine, methadone, and naltrexone work, who they're for, and the myths that keep people away.
- May 8The Crisis, By the Numbers
The Treatment Gap: Why Only 1 in 7 Americans with SUD Get Help
Why only 15% of Americans with SUD get treatment — the five structural reasons behind the treatment gap and what would fix them.
- May 8The Crisis, By the Numbers
Alcohol: America's Quieter Epidemic
Alcohol-induced deaths in the U.S. reached 105,400 in 2022, up 30% since the pandemic. The quiet half of the crisis.
- May 8The Crisis, By the Numbers
Fentanyl, Still Driving Overdose Deaths in 2026
Updated 2026 fentanyl data: share of overdose deaths, polysubstance patterns, and why the illicit supply is becoming more complex.
- May 8Lived Experience & Community
If Someone You Love Has a Substance Use Disorder: The Family Guide
A trauma-informed family guide to substance use disorder: what to say, what not to, intervention myths, Al-Anon, and setting boundaries.
- May 8Technology & Innovation
The State of Recovery Technology in 2026
The 2026 landscape for recovery technology — digital therapeutics, AI, telehealth MAT, and the companies shaping the space.
- May 8Arizona Watch
Arizona's Recovery Infrastructure in 2026
Inside Arizona's recovery system in 2026 — AHCCCS, opioid settlement spending, Maricopa county services, and the treatment gap that refuses to close.
- May 8Harm Reduction
Living Through the Fentanyl Era: A Harm Reduction Primer
A practical harm reduction primer: how to use naloxone, how test strips work, what xylazine is, and Good Samaritan law basics.
- May 8Science & Medicine
The Science of Addiction in 2026: What We Actually Know
What addiction science actually says in 2026 — brain mechanisms, genetics, medications that work, and emerging treatments.
- May 8Treatment & Recovery
How to Find Addiction Treatment in America: The 2026 Guide
A practical, trauma-informed guide to finding addiction treatment in 2026 — SAMHSA, 211, insurance, and what to actually ask.
- May 8Policy & Funding
The 2026 U.S. Addiction Policy Landscape
2026 addiction policy overview: extended telehealth prescribing, SAMHSA grants, Medicaid risk, IMD waivers, opioid settlements.
- May 8The Crisis, By the Numbers
The U.S. Substance Use Crisis in 2026: By The Numbers
Definitive 2026 overview of U.S. substance use: overdose trends, SUD prevalence, fentanyl's grip, the treatment gap, and what's changing.
April 2026
- Apr 28Harm Reduction
Xylazine: What Frontline Workers Need to Know
Xylazine — α-2 agonist not reversed by naloxone — has spread to all 50 states. Here's what changes for first responders, harm reduction services, and people who use drugs.
- Apr 25Harm Reduction
Living Through the Fentanyl Era
Fentanyl has not just replaced heroin. It has changed what addiction looks like, what overdose looks like, and what recovery has to mean in 2026.
- Apr 24Treatment & Recovery
MAT in 2026: What It Is, What It Isn't
Buprenorphine, methadone, and naltrexone remain the three FDA-approved medications for OUD — and the most under-prescribed life-saving treatments in American medicine.